Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant

SARS-CoV-2 Mu variant emerged in Colombia in 2021 and spread globally. In 49 serum samples from vaccinees and COVID-19 survivors in Colombia, neutralization was significantly lower (p<0.0001) for Mu than a parental strain and variants of concern. Only the Omicron variant of concern demonstrated h...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira-Filho, Edmilson F., Rincon-Orozco, Bladimiro, Jones-Cifuentes, Natalia, Peña-López, Brigitte, Mühlemann, Barbara, Drosten, Christian, Moreira-Soto, Andres, Drexler, Jan Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328909/
https://www.ncbi.nlm.nih.gov/pubmed/35830278
http://dx.doi.org/10.3201/eid2808.220584
_version_ 1784757820900507648
author de Oliveira-Filho, Edmilson F.
Rincon-Orozco, Bladimiro
Jones-Cifuentes, Natalia
Peña-López, Brigitte
Mühlemann, Barbara
Drosten, Christian
Moreira-Soto, Andres
Drexler, Jan Felix
author_facet de Oliveira-Filho, Edmilson F.
Rincon-Orozco, Bladimiro
Jones-Cifuentes, Natalia
Peña-López, Brigitte
Mühlemann, Barbara
Drosten, Christian
Moreira-Soto, Andres
Drexler, Jan Felix
author_sort de Oliveira-Filho, Edmilson F.
collection PubMed
description SARS-CoV-2 Mu variant emerged in Colombia in 2021 and spread globally. In 49 serum samples from vaccinees and COVID-19 survivors in Colombia, neutralization was significantly lower (p<0.0001) for Mu than a parental strain and variants of concern. Only the Omicron variant of concern demonstrated higher immune evasion.
format Online
Article
Text
id pubmed-9328909
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-93289092022-08-06 Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant de Oliveira-Filho, Edmilson F. Rincon-Orozco, Bladimiro Jones-Cifuentes, Natalia Peña-López, Brigitte Mühlemann, Barbara Drosten, Christian Moreira-Soto, Andres Drexler, Jan Felix Emerg Infect Dis Dispatch SARS-CoV-2 Mu variant emerged in Colombia in 2021 and spread globally. In 49 serum samples from vaccinees and COVID-19 survivors in Colombia, neutralization was significantly lower (p<0.0001) for Mu than a parental strain and variants of concern. Only the Omicron variant of concern demonstrated higher immune evasion. Centers for Disease Control and Prevention 2022-08 /pmc/articles/PMC9328909/ /pubmed/35830278 http://dx.doi.org/10.3201/eid2808.220584 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
de Oliveira-Filho, Edmilson F.
Rincon-Orozco, Bladimiro
Jones-Cifuentes, Natalia
Peña-López, Brigitte
Mühlemann, Barbara
Drosten, Christian
Moreira-Soto, Andres
Drexler, Jan Felix
Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title_full Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title_fullStr Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title_full_unstemmed Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title_short Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
title_sort effectiveness of naturally acquired and vaccine-induced immune responses to sars-cov-2 mu variant
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328909/
https://www.ncbi.nlm.nih.gov/pubmed/35830278
http://dx.doi.org/10.3201/eid2808.220584
work_keys_str_mv AT deoliveirafilhoedmilsonf effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT rinconorozcobladimiro effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT jonescifuentesnatalia effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT penalopezbrigitte effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT muhlemannbarbara effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT drostenchristian effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT moreirasotoandres effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant
AT drexlerjanfelix effectivenessofnaturallyacquiredandvaccineinducedimmuneresponsestosarscov2muvariant

Ejemplares similares